Cargando…
Carbonic Anhydrase IX in Renal Cell Carcinoma, Implications for Disease Management
Carbonic Anhydrase IX (CAIX) is a well-described enzyme in renal cell carcinoma, with its expression being regulated by the hypoxia-inducible factor 1 alpha, it is known for interfering with hypoxia processes. Renal carcinoma encompasses a broad spectrum of histological entities and is also describe...
Autores principales: | Courcier, Jean, de la Taille, Alexandre, Nourieh, Maya, Leguerney, Ingrid, Lassau, Nathalie, Ingels, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582814/ https://www.ncbi.nlm.nih.gov/pubmed/32998233 http://dx.doi.org/10.3390/ijms21197146 |
Ejemplares similares
-
BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model
por: Courcier, Jean, et al.
Publicado: (2023) -
Ultrasound Molecular Imaging of Renal Cell Carcinoma: VEGFR targeted therapy monitored with VEGFR1 and FSHR targeted microbubbles
por: Ingels, Alexandre, et al.
Publicado: (2020) -
Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell Carcinoma
por: Leguerney, Ingrid, et al.
Publicado: (2017) -
Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients
por: Závada, J, et al.
Publicado: (2003) -
Surgical and oncological management of renal medullary carcinoma in a young patient: a case report
por: Courcier, Jean, et al.
Publicado: (2023)